General Information of Drug (ID:
DR5212) |
Drug Name |
Emedastine
|
Synonyms |
Emadine; Emedastina; Emedastinum; Emedastine [INN]; Emedastine difumarate; KB 2413; KG 2413; Emadine (TN); Emedastina [INN-Spanish]; Emedastine (INN); Emedastine [INN:BAN]; Emedastinum [INN-Latin]; KB-2413; KG-2413; 1-(2-Ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate; 1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole; 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole; 1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole; 1-Methyl-4-(1-(2-ethoxyethyl)-1H-benzimidazo)-2-yl)(1,4)diazepane; 1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole
|
Indication |
Conjunctivitis
[ICD11: 9A60]
|
Approved
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
302.4 |
Topological Polar Surface Area |
33.5 |
Heavy Atom Count |
22 |
Rotatable Bond Count |
5 |
Hydrogen Bond Donor Count |
0 |
Hydrogen Bond Acceptor Count |
4 |
Cross-matching ID |
- PubChem CID
- 3219
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D02XJI
- Formula
- C17H26N4O
- Canonical SMILES
- CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
- InChI
- InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3
- InChIKey
- KBUZBQVCBVDWKX-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.